Loading term…
FDA programme to manage serious risks of a drug; may include ETASU (elements to assure safe use), communication plan, and implementation system.
REMS with restricted distribution and pregnancy testing for a teratogen.
FDA FDAAA, 21 CFR Part 208
Treating REMS as optional or not tracking compliance metrics.
How do you ensure REMS compliance and document effectiveness?